Abstract
Vasomotor symptoms (VMS) such as hot flashes and night sweats are intense and rapid sensations of internal heat, peripheral vasodilation, and profuse sweating that can be debilitating. They occur due to central norepinephrine discharge and narrowing of the core body thermoneutral zone with dropping brain estrogen levels in women and men. Therapy options for the treatment of VMS in post-menopausal women have been widely studied. However, the treatment strategies for VMS that occur in some transgender men who have undergone oophorectomy have not been reported. A 35-year-old female-to-male (FTM) transgender man presented with symptoms of severe and frequent VMS that began shortly after total hysterectomy and oophorectomy. The patient was treated with a stable dose of testosterone for gender affirmation and previous attempts to increase his testosterone dose did not relieve the VMS. In addition to his testosterone therapy, 0.025 - 0.0375 mg twice per week of transdermal estradiol was added to his hormonal regimen. Addition of estradiol completely relieved the vasomotor symptoms and masculinization was not affected. Discontinuation of estradiol led to the recurrence of VMS at the same severity as previously experienced, which was associated with a low level of serum estrogen. Vasomotor symptoms in a transgender man taking testosterone were successfully treated with the addition of transdermal estradiol.
Funding Information
  • National Institutes of Health (T32DK007011)

This publication has 13 references indexed in Scilit: